Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$471K Sell
3,669
-142
-4% -$16.6K 0.16% 59
2026
Q1
$458K Sell
3,811
-92
-2% -$10.6K 0.18% 56
2025
Q4
$411K Sell
3,903
-386
-9% -$36.2K 0.18% 58
2025
Q3
$360K Hold
4,289
0.2% 63
2025
Q2
$340K Sell
4,289
-535
-11% -$42.5K 0.21% 63
2025
Q1
$433K Hold
4,824
0.29% 52
2024
Q4
$480K Buy
4,824
+3,000
+164% +$309K 0.32% 52
2024
Q3
$207K Sell
1,824
-63
-3% -$7.49K 0.14% 102
2024
Q2
$234K Sell
1,887
-38
-2% -$4.89K 0.18% 90
2024
Q1
$254K Sell
1,925
-184
-9% -$22.7K 0.19% 80
2023
Q4
$230K Buy
+2,109
New +$219K 0.18% 87
2023
Q1
$254K Buy
+1,925
New +$208K 0.19% 80

Other funds holding MRK

Fidelity D&D Bancorp's MRK Position: Q2 2026 in Review

Fidelity D&D Bancorp reduced its Merck (MRK) stake by 3.7% in Q2 2026, selling an estimated $16.6K and leaving 3,669 shares worth $471K. The position accounts for 0.16% of the portfolio, ranked #59.

Fidelity D&D Bancorp first reported a position in MRK in Q1 2023 and has held it in 12 quarters since. The position peaked at $480K in Q4 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Fidelity D&D Bancorp held 3,669 shares of Merck worth $471K as of Q2 2026.
  • Fidelity D&D Bancorp sold 142 Merck shares in Q2 2026, an estimated $16.6K.
  • Merck made up 0.16% of Fidelity D&D Bancorp's portfolio in Q2 2026, its #59 holding.
  • Fidelity D&D Bancorp first reported a position in Merck in Q1 2023 and has held it in 12 quarters since.
  • Fidelity D&D Bancorp's Merck position peaked at $480K in Q4 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Fidelity D&D Bancorp's 13F filing for Q2 2026, filed 6 Aug 2026.